Germán Velásquez

South Centre

17-19 Chemin du Champ d'Anier

Geneva, Geneva 1211

Switzerland

SCHOLARLY PAPERS

3

DOWNLOADS

36

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock

Number of pages: 10 Posted: 01 Jul 2020
Germán Velásquez
South Centre
Downloads 19 (580,307)

Abstract:

Loading...

Access to Medicines, Affordable Medicines, Coronavirus, COVID-19, Diagnostics, Global Health, Health, Innovation, Intellectual Property, Pandemic, Patent, Pharmaceuticals, Public Health, Research and Development (R&D), TRIPS, Vaccines, World Health Organization (WHO)

2.

Access to Medicines: Experiences with Compulsory Licenses and Government Use - The Case of Hepatitis C

South Centre Research Paper No. 85
Number of pages: 46 Posted: 16 Apr 2020
Carlos M. Correa and Germán Velásquez
University of Buenos Aires (UBA) - Faculty of Social Sciences and South Centre
Downloads 10 (634,291)

Abstract:

Loading...

Access to Medicines, Compulsory Licenses, Dispute Settlement, Health, Hepatitis C, Innovation, Intellectual Property, Patent, Research and Development (R&D), TRIPS, World Health Assembly (WHA), World Health Organization (WHO)

3.

Medicines and Intellectual Property: 10 Years of the WHO Global Strategy

South Centre Research Paper No. 100
Number of pages: 50 Posted: 16 Apr 2020
Germán Velásquez
South Centre
Downloads 7 (655,771)
Citation 1

Abstract:

Loading...

Access to Medicines, Affordable Medicines, Biosimilars, Biotherapeutics, Framework Convention on Tobacco Control (FCTC) , Global Health , Health , Innovation , Intellectual Property, Inter-Governmental Working Group (IGWG), Public Health, Research and Development (R&D), Transparency, TRIPS